Dr. John C. Deysine, MD

  • Flushing, NY
  • Surgical oncologist
NPI1881607216PAC ID9537213764
Medicare services, 2024
399
Medicare patients, 2024
267
Part D claims, 2024
43
MIPS score, 2024
94
Hospital affiliations
1
Practice address
158-6 Northern Blvd, Flushing, NY 11358
Practice phone
Call (718) 517-2900
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Brooklyn Radiation Oncology

Flushing, New York

See all 6 affiliations

Find Dr. Deysine's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. John C. Deysine is a surgical oncologist in Flushing, New York

Dr. Deysine practices at Brooklyn Radiation Oncology in Flushing, New York.

Dr. Deysine's NPI, 1881607216, was assigned on August 15, 2006. Dr. Deysine holds New York license 181541.

NPI and contact details
Medicare PAC ID
9537213764
NPI enumeration date
August 15, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(718) 517-2900
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
65
Medical school graduation
1987

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. John C. Deysine practices at Brooklyn Radiation Oncology in Flushing, New York

Dr. Deysine's primary practice is Brooklyn Radiation Oncology, at 158-6 Northern Blvd, Flushing, NY 11358 in Queens County. The practice phone is (718) 517-2900.

  • Brooklyn Radiation Oncology
    158-6 Northern Blvd, Flushing, NY 11358 · Queens CountyPhone(718) 517-2900

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. John C. Deysine is affiliated with 3 sites of care and 3 medical groups

Dr. Deysine's primary practice is Brooklyn Radiation Oncology in Flushing, New York. Dr. Deysine is also affiliated with Staten Island University Hospital. The medical group on file is NewYork-Presbyterian Medical Group/Westchester. Dmand AI also links Dr. Deysine to 2 more medical groups and 1 group practice or clinic, each named with a free account.

See all 6 affiliations for Dr. Deysine

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. John C. Deysine's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Deysine practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Brooklyn Radiation OncologyAvailable with a free account
+2 more sites and 2 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Deysine practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. John C. Deysine is one of 162 surgical oncologists in New York

Surgical oncology is Dr. Deysine's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Deysine is licensed in New York.

Specialties and state licenses

  • Surgical oncology, New YorkPrimaryLicense 181541 · taxonomy 2086X0206X

Surgical oncologists near Dr. Deysine

Counts of surgical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

162surgical oncologists in New York
5surgical oncologists in Flushing

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. John C. Deysine billed Medicare for 399 services in 2024

CMS data shows 399 Medicare services from Dr. Deysine across 3 procedure codes in 2024, all of them office visits, for 267 Medicare patients. Medicare paid $43,395 for them.

Medicare services, 2024399
Medicare patients267
Paid by Medicare$43,395
Procedure codes3

Dr. Deysine's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 4012024: 399No change
Surgery
2023: 142024: 0100%

Where Dr. Deysine's Medicare services took place, 2024

  • In an office38496%
  • In a facility154%

Dr. Deysine compared with the New York median for surgical oncologists, 2024

  • Dr. Deysine
  • New York median
Medicare services
399vs 1243.2 times
Medicare patients
267vs 962.8 times
Part D claims
28vs 1587% above

Medians across 145 surgical oncologists in New York with Dmand AI profiles that report each measure.

Dr. Deysine's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Deysine

Need commercial claims for Dr. Deysine?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Deysine and other surgical oncologists in New York.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. John C. Deysine treated 267 Medicare patients in 2024, average age 74

CMS counts 267 Medicare patients who saw Dr. Deysine in 2024. The largest group is 65 to 74, with 120 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Deysine's median patient age at 68, with 92% women.

Medicare patients, 2024267
Average age74
Average risk score1.07
Also on Medicaid22%

Dr. Deysine's Medicare patients by age, 2024

Chronic conditions among Dr. Deysine's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis52%
  4. Diabetes50%
  5. Cancer43%
  6. Osteoporosis29%
  7. Anxiety26%
  8. Ischemic heart disease24%

Share of Medicare patients with each condition. A patient can have several.

Dr. Deysine's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 68

Patient panel by sex, all payers

  • Women92%
  • Men5%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. John C. Deysine wrote 43 Medicare Part D claims in 2024

In 2024, Dr. Deysine wrote 43 Medicare Part D claims for 12 patients. 95% of them were for generic drugs. CMS names the drug for 28 of them, across 2 drugs with 11 or more claims each, at $259 in total drug cost. In 2023, CMS named 23 claims across 2 drugs.

Part D claims, 202443
Drugs named by CMS2
Total drug cost$259
Part D patients12

Dr. Deysine's Part D claims by kind of drug, 2024

  • Generic41 claims95%
  • Brand-name and other2 claims5%

Dr. Deysine's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 232024: 2822%

Drugs named by CMS: 2 in 2024, 2 in 2023.

See all prescribing by Dr. Deysine

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. John C. Deysine scored 94 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Deysine for performance year 2024, reported as part of a group. Dr. Deysine accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Deysine as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Deysine's MIPS scores, performance year 2024

  • 94of 100Final score
  • 84.7of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 71of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Sources: Doctors and Clinicians National Downloadable File (CMS); Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026; and Doctors and Clinicians Utilization Data (CMS)

For MedTech and pharma teams

Find surgical oncologists like Dr. Deysine by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. John C. Deysine received $184 in industry payments in 2025

CMS Open Payments shows 7 general payments to Dr. Deysine from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Sumitomo Pharma America, Inc. paid the most, $184.

Companies that paid Dr. Deysine the most, 2025 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Deysine

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. John C. Deysine's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. John C. Deysine

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. John C. Deysine's NPI number?

Dr. John C. Deysine's NPI number is 1881607216. It was assigned on August 15, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. John C. Deysine?

Dr. John C. Deysine is a surgical oncologist in Flushing, New York. The primary specialty in the NPI Registry is Surgical Oncology Physician (taxonomy code 2086X0206X).

Where does Dr. John C. Deysine practice?

Dr. Deysine practices at 158-6 Northern Blvd, Flushing, NY 11358. Dr. Deysine's primary practice is Brooklyn Radiation Oncology in Flushing, New York. Dmand AI also links Dr. Deysine to 2 medical groups and 1 group practice or clinic.

What is Dr. John C. Deysine's office phone number?

The practice phone on file for Dr. Deysine is (718) 517-2900.

What is Dr. John C. Deysine's medical license number?

Dr. Deysine holds New York license 181541.

Which hospitals is Dr. John C. Deysine affiliated with?

Dr. Deysine is affiliated with Staten Island University Hospital.

What medical group is Dr. John C. Deysine part of?

Dr. Deysine is linked to NewYork-Presbyterian Medical Group/Westchester. Dmand AI links Dr. Deysine to 2 more medical groups.

Does Dr. John C. Deysine accept Medicare?

Yes. CMS data shows Dr. Deysine billed Medicare for 399 services in 2024, and Dr. Deysine accepts Medicare assignment.

Does Dr. John C. Deysine offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Deysine as offering telehealth services.

What is Dr. John C. Deysine's MIPS score?

Dr. Deysine's MIPS final score for performance year 2024 is 94 out of 100, reported as part of a group.

Show 5 more questionsShow fewer questions

How many Medicare patients does Dr. John C. Deysine see?

CMS counts 267 Medicare patients who saw Dr. Deysine in 2024, with an average age of 74.

What services does Dr. John C. Deysine bill to Medicare?

In 2024, Dr. Deysine's most billed Medicare services were office visit, established patient (99214), office visit, new patient (99204) and office visit, established patient (99213).

What drugs does Dr. John C. Deysine prescribe most?

In 2024 Medicare Part D data, Dr. Deysine's most prescribed drugs by claims were Anastrozole and Exemestane.

Has Dr. John C. Deysine received payments from drug or device companies?

CMS Open Payments shows $184 in general payments to Dr. Deysine from 1 company from 2025 to 2025. The largest total came from Sumitomo Pharma America, Inc.

How long has Dr. John C. Deysine been practicing?

Dr. Deysine graduated from medical school in 1987, 39 years ago.

Selling to surgical oncology practices?

See surgical oncologists in New York by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)